On Thursday, Healthcare Trust Of America Inc (NYSE:HTA)’s shares declined -1.80% to $25.02.
Healthcare Trust of America, Inc. (HTA), declared that on Wednesday, July 29, before the market opens, it will report second quarter financial results. The Company will host a conference call and webcast on Wednesday, July 29, 2015 at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time) to review its financial performance and operating results for the quarter ended June 30, 2015.
Healthcare Trust of America, Inc. is a publicly owned equity real estate investment trust. The firm invests in the real estate markets of the United States. It is engaged in acquiring, owning and operating high-quality medical office buildings located primarily on-campus or associated with the nation’s leading healthcare systems. Healthcare Trust of America, Inc. was founded on April 20, 2006 and is based in Scottsdale, Arizona.
Qualys Inc (NASDAQ:QLYS)’s shares gained 5.80% to $39.03.
Qualys, Inc. (QLYS), a pioneer and leading provider of cloud security and compliance solutions, recently declared that the company will report its financial results for the second quarter of 2015 after the market closes on Monday, August 3, 2015.
Qualys, Inc. provides cloud security and compliance solutions in the United States and internationally. The company offers QualysGuard cloud suite of solutions, such as Vulnerability Administration, Policy Compliance, PCI Compliance, Web Application Scanning, Malware Detection Service, Web Application Firewall, and Qualys SECURE Seal. Its integrated suite of security and compliance solutions delivered on its QualysGuard Cloud Platform enables customers to identify their IT assets, collect and analyze large amounts of IT security data, discover and prioritize vulnerabilities, recommend remediation actions, and verify the implementation of such actions.
At the end of Thursday’s trade, H&E Equipment Services, Inc. (NASDAQ:HEES)‘s shares dipped -10.91% to $14.78.
H&E Equipment Services, Inc. (HEES) declared that it will release its 2015 second quarter financial results before the market on Thursday, July 30, 2015. The Company will also hold a conference call to talk about second quarter results on Thursday, July 30, 2015, at 10:00 a.m. (Eastern Time). To listen to the call, participants should dial 913-312-1475 about 10 minutes preceding to the start of the call. A telephonic replay will become accessible after 1:00 p.m. (Eastern Time) on July 30, 2015, and will continue through August 8, 2015, by dialing 719-457-0820 and entering the confirmation code 2887928.
H&E Equipment Services, Inc. operates as an integrated equipment services company. The company rents, sells, and provides parts and service support for hi-lift or aerial work platform equipment, crane, earthmoving equipment, and industrial lift truck categories. It offers heavy construction and industrial equipment for rent on a daily, weekly, and monthly basis. As of December 31, 2014, the company’s rental fleet comprised of 26,056 pieces of equipment.
Laboratory Corp. of America Holdings (NYSE:LH), ended its Thursday’s trading session with 1.32% gain, and closed at $122.78.
Laboratory Corp. of America Holdings (LH) declared that Covance Drug Development has relocated its clinical research unit (CRU) in Dallas, TX, to a new, fit-for-purpose clinical research facility. The new unit, which opened earlier this month, has expanded from 72 to 100 medical beds and is located in the same building as the preceding unit. In addition, a LabCorp patient service center will be co-located in the CRU, at which patients will have an opportunity to learn more about volunteering and participating in early stage clinical trials.
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, STD tests, HCV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by the medical profession in core testing, patient diagnosis, and in the monitoring and treatment of diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
